Kevin Kaijun Li
Vorsitzender bei Neurelis, Inc.
Profil
Kevin Kaijun Li is currently the Chairman at Neurelis, Inc. and the Director at Wugen, Inc. Previously, he worked as an Associate at Toucan Capital Corp.
from 2004 to 2005.
He holds a doctorate degree from Indiana University and an undergraduate degree from Nankai University.
Aktive Positionen von Kevin Kaijun Li
| Unternehmen | Position | Beginn |
|---|---|---|
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Vorsitzender | - |
Wugen, Inc.
 Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kevin Kaijun Li
| Unternehmen | Position | Ende |
|---|---|---|
Toucan Capital Corp.
 Toucan Capital Corp. Investment ManagersFinance Toucan Capital Corp (Toucan Capital) is a private equity firm founded in 1997 by Linda F. Powers and Robert F. Hemphill. The firm is headquartered in Bethesda, Maryland. | Private-Equity-Analyst | 14.07.2005 |
Ausbildung von Kevin Kaijun Li
| Nankai University | Undergraduate Degree |
| Indiana University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Toucan Capital Corp.
Toucan Capital Corp. Investment ManagersFinance Toucan Capital Corp (Toucan Capital) is a private equity firm founded in 1997 by Linda F. Powers and Robert F. Hemphill. The firm is headquartered in Bethesda, Maryland. | Finance |
Neurelis, Inc.
Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Health Technology |
Wugen, Inc.
Wugen, Inc. Packaged SoftwareTechnology Services Wugen, Inc. develops CAR-T therapy platform for cancer therapies. The company was founded by Matthew Cooper and John F. DiPersio and is headquartered in St. Louis, MO. | Technology Services |
